-
1 Comment
Xinjiang Baihuacun Co., Ltd is currently in a long term uptrend where the price is trading 30.6% above its 200 day moving average.
From a valuation standpoint, the stock is 218.8% more expensive than other stocks from the Consumer Cyclical sector with a price to sales ratio of 16.4.
Xinjiang Baihuacun Co., Ltd's total revenue sank by 95.1% to $3M since the same quarter in the previous year.
Its net income has dropped by 1699.3% to $-278M since the same quarter in the previous year.
Finally, its free cash flow fell by 257.2% to $-31M since the same quarter in the previous year.
Based on the above factors, Xinjiang Baihuacun Co., Ltd gets an overall score of 1/5.
| Exchange | SHG |
|---|---|
| ISIN | CNE000000KQ1 |
| CurrencyCode | CNY |
| Sector | Consumer Cyclical |
| Industry | Restaurants |
| Beta | 0.15 |
|---|---|
| Market Cap | 3B |
| PE Ratio | 62.82 |
| Target Price | None |
| Dividend Yield | None |
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd engages in the pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses. The company was formerly known as Xinjiang Baihuacun Co., Ltd. and changed its name to Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd in July 2021. Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd was founded in 1959 and is based in Urumqi, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600721.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
